SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 0.31 |
| Enterprise Value ($M) | 0.35 |
| Book Value ($M) | -0.91 |
| Book Value / Share | -0.00 |
| Price / Book | -0.34 |
| NCAV ($M) | -0.93 |
| NCAV / Share | -0.00 |
| Price / NCAV | -0.34 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | 1.59 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.16 |
| Current Ratio | 0.16 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 0.17 |
| Assets | 0.19 |
| Liabilities | 1.10 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.13 |
| Operating Income | -0.00 |
| Net Income | -0.01 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Reconciliation Disclosure | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.03 |
| Cash from Investing | 0.00 |
| Cash from Financing | -0.02 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| RVLPQ – RVL Pharmaceuticals plc | SCPS – Scopus BioPharma Inc. |
| SEELQ – Seelos Therapeutics, Inc. | SGFEF – Siegfried Holding AG |
| SIGO – Sunset Island Group, Inc. |
Financial data and stock pages provided by
Fintel.io